作为我国药品出口最重要的一类产品，维生素今年整体出口形势并不乐观。据中国医药保健品进出口商会（以下简称“医保商会”）公布的最新数据显示，今年前5个月，拳头产品维生素出口量继续萎缩。然而祸不单行，进入7月以来，其原本坚挺的价格也开始呈现出走低态势。为缓解近期困境，维生素企业开始减产提价，但分析师坦言，由于产能过剩，这一惯用的救市方法可能难以奏效。

As the most important export our drug of a class of products，This year the export situation is not whole vitamin optimistic。According to the Chinese medicine health products import and export Chambers of commerce（Hereinafter referred to as“Medical insurance chamber of commerce”）Released figures showing，The first five months of this year，Blockbuster products vitamin exports continue to atrophy。But it never rains but it pours，Since July into，It was a strong price began to present a lower situation。In order to alleviate the recent difficulties，Vitamin enterprise began to cut prices，But analysts said，Because of excess capacity，This often help city methods may not work。

　　出口量持续下滑

Exports continued to slide

　　医保商会表示，中国维生素企业凭借先进的制造工艺，一直在国际市场占有举足轻重的地位，优势产品维生素C、维生素E、维生素A和维生素B族是出口主导型产品。但今年1-5月，我国维生素类产品出口7.58万吨，同比减少6.34%。

Medical insurance chamber of commerce said，China vitamin enterprise with advanced manufacturing process，In the international market has been pivotal status，Advantage products vitamin C、Vitamin E、Vitamin A, and vitamin B clan is export leading products。But this year 1-5 month，Our country vitamin products export 75800 tons，Reduce 6.34% year-on-year。

　　对于出口量下滑，医保商会相关负责人指出，今年前5个月，受国际经济大环境低迷的影响，维生素类产品出口数量普遍减少，两个主要单品维生素C和维生素E的出口量同比分别减少14.2%和11.62%。此外，维生素类产品中出口量下降幅度较大的还有维生素B1和B12，同比分别减少了20.36%和50.02%。

For exports to slide，The relevant person in charge of medical insurance chamber of commerce said，The first five months of this year，By international economic environment the influence of the downturn，Vitamin products export quantity generally decrease，Two main single product vitamin C and vitamin E exports respectively compared to reduce by 14.2% and 11.62%。In addition，Vitamin products export declines greatly and vitamin B1 and B12，Year-on-year are reduced to 20.36% and 50.02%。

　　从价格来看，维生素C出口数量在连续两年激增后市场呈现疲态，囤货量巨大，出口价格开始下跌，跌幅高达24.29%；维生素E受饲料行业不景气影响，市场需求欠佳，但价格相对坚挺，今年前5个月出口价格同比增长11.22%。

From the point of the price，Vitamin C in export quantity for two years after the market started to surge in present，Store the great amount of goods，Export prices start to fall，Fall as much as 24.29%；Vitamin E feed industry recession by influence，Poor market demand，But the relative price of strong，The first five months of this year export prices up 11.22%。

　　7月起价格走低

July prices were low

　　进入7月份，维生素市场上悲观情绪浓重。来自医药统计网站的数据也显示，近1个月来，维生素市场行情总体低迷。

Into July，Vitamin market pessimism dense。Statistics from medicine web site the data also show，Nearly a month to，Vitamin market overall downturn。

　　事实上，近年来维生素行业一直笼罩在产能过剩的阴影中。有关资料显示，维生素E的价格在2009年曾高达495元/千克，在2010年11月份却戏剧性地跌至83元/千克，虽然后来价格一度回涨，但难以改变降价局面，至今售价在115元/千克徘徊，并仍存在降价可能。

In fact，In recent years, the industry has been shrouded in vitamin excess capacity in the shadow。Relevant data shows，Vitamin E price in 2009 was as high as 495 yuan/kg，In November 2010 but dramatically dropped to 83 yuan/kg，Although prices at the HuiZhang later，But difficult to change the price cut situation，So far in 115 yuan/kg for wandering，And still may depreciate。

　　业内分析师认为，维生素价格下滑与产能过剩有着直接关系。以维生素C为例，目前中国已建和拟建的产能已经达到20多万吨/年，而全球的需求量每年仅为十多万吨。正是由于盲目扩产，曾导致维生素C价格大跌，并且逐渐丧失了国际市场的定价话语权。

Industry analysts think，Vitamin price declines and excess capacity is a direct relationship。With vitamin C for example，At present China has built and the proposed capacity has reached more than 20 ten thousand tons/year，And the demand for more than a year just ten thousand tons。It is because of blind expansion，Has led to vitamin C prices plunged，And gradually lose the international market pricing right。

　　减产提价难奏效

Cut prices to bear fruit

　　眼看需求不振、产能过剩再加上价格下探，国内维生素生产企业被迫使出减产提价这一常用招数。日前，浙江医药披露，决定于8月初对下属主要生产企业新昌制药厂、绍兴袍江维生素厂进行全面停产检修。虽然该公司工作人员坚称停产检修是正常工作事项，但业内专家仍认为这是为抬价做的铺垫。

See demand of、Excess capacity plus price dip，Domestic production enterprise was forced to use vitamin price cut the commonly used gimmick。a，Zhejiang pharmaceutical disclosure，In early August decision to subordinate the main production enterprise hsin chong pharmaceutical factory、Shaoxing robe jiang vitamin plant production comprehensive overhaul。Although the company staff insisted that production is normal maintenance work matters，But industry experts are still think this is central to the matting。

　　不仅如此，业内盛传，其他维生素生产厂商也将紧随浙江医药采取停产措施。然而面对多个产品下游需求疲软，停产提价是否能够见效呢？对此，相关专家坦言，限产提价原本是维生素领域的“行规”，但近年来维生素出口下滑，企业靠限产保价已经十分不易，要想促使价格上扬非常困难。

Not only that，The rumours，Other vitamin production manufacturer also will follow zhejiang pharmaceutical production measures taken。But dealing with multiple product downstream demand weak，Whether can effective production raise prices？this，Related experts said，XianChan prices is originally in the field of vitamins“Guild regulations”，But in recent years the vitamin export slowdown，XianChan enterprise depends on the insured has been very not easy，Want to get prices very difficult。

　　另外，一位不愿具名的药企负责人指出，由于产能过剩，且需求情况不如从前，在维生素限产政策尚未被严格执行之前，维生素的低迷行情还将持续一段时间。

In addition，An anonymous medicine enterprises chief said，Because of excess capacity，And demand as before，In vitamin XianChan policy has not been strictly carry out before，The market downturn will also be vitamin continued over a period of time。